<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02083575</url>
  </required_header>
  <id_info>
    <org_study_id>vitamin c and iron chelator</org_study_id>
    <nct_id>NCT02083575</nct_id>
  </id_info>
  <brief_title>Role of Vitamin C to Augment Iron Chelation With DFP or DFX</brief_title>
  <official_title>Study of Safty and Efficacy of Adjuvant Vitamin c in Augmenting Iron Chelation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ain Shams University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ain Shams University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      role of Vit C to Augment iron chelation with DFP or DFX in thalassemic patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      assess safety and efficacy of Vit C to Augment iron chelation with DFP or DFX in thalassemic
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>April 2014</start_date>
  <completion_date type="Anticipated">April 2014</completion_date>
  <primary_completion_date type="Anticipated">April 2014</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vit C to Augment iron chelation</measure>
    <time_frame>12 months</time_frame>
    <description>assess safety and efficacy of Vit C to Augment iron chelation with DFP or DFX in thalassemic patients.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>vitamin c augmenting effect of iron chelator</measure>
    <time_frame>12 month</time_frame>
    <description>better reduction in serum ferritin, LIC and cardiac T28 in group receiving vitamin c</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>adverse related events</measure>
    <time_frame>12 month</time_frame>
    <description>safety and occurrence of AEs in both studied groups</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Vitamin c</condition>
  <condition>Thalassemia Major</condition>
  <condition>Iron Chelation</condition>
  <arm_group>
    <arm_group_label>vitamin c</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 heavily iron-loaded thalassemia patients, receiving adjuvant vitamin c with iron chelator.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>iron chelator</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Included 25 heavily iron-loaded thalassemia patients, not receiving adjuvant vitamin c with iron chelator.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Vitamin C, Defriprone, deferisarox</intervention_name>
    <description>adjuvant vitamin c with iron chelator.</description>
    <arm_group_label>vitamin c</arm_group_label>
    <other_name>vitamin c</other_name>
    <other_name>DFP</other_name>
    <other_name>DFX</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>deferiprone , deferesarox</intervention_name>
    <description>iron chelator</description>
    <arm_group_label>iron chelator</arm_group_label>
    <other_name>DFP</other_name>
    <other_name>DFX</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  • Subjects with overload secondary to thalassemia major

        Exclusion Criteria:

          -  • with HIV positive or have active HCV.

               -  A history of serious immunologic hypersensitivity to any medication such as
                  anaphylaxis or angioedema.

               -  Participation in a previous investigational drug study within the 30 days
                  preceding screening.

               -  A woman of childbearing potential must have a negative serum pregnancy test at
                  screening. She must use a medically acceptable form of birth control during the
                  study and for a month afterwards who are pregnant or breast-feeding.

               -  An inability to adhere to the designated procedures and restrictions of this
                  protocol.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>6 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>MOHSEN S ELALFY, PROF.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Ain Shams University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>MOHSEN S ELALFY, PROF.</last_name>
    <email>AMIRADIABETES@YAHOO.COM</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pediatric Hematology clinic, Ain Shams University Egypt</name>
      <address>
        <city>Cairo,</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>MOHSEN S ELALFY, PROF</last_name>
      <email>AMIRADIABETES@YAHOO.COM</email>
    </contact>
    <investigator>
      <last_name>MOHSEN S ELALFY, PROF</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 7, 2014</study_first_submitted>
  <study_first_submitted_qc>March 7, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 11, 2014</study_first_posted>
  <last_update_submitted>March 7, 2014</last_update_submitted>
  <last_update_submitted_qc>March 7, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">March 11, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ain Shams University</investigator_affiliation>
    <investigator_full_name>Mohsen Saleh Elalfy</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <keyword>vitamin c</keyword>
  <keyword>thalassemia major</keyword>
  <keyword>iron chelation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thalassemia</mesh_term>
    <mesh_term>beta-Thalassemia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Vitamins</mesh_term>
    <mesh_term>Ascorbic Acid</mesh_term>
    <mesh_term>Iron</mesh_term>
    <mesh_term>Deferiprone</mesh_term>
    <mesh_term>Chelating Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

